Key result
Lower LV mechanical dispersion in ATTR-CM vs non-amyloid LVH is linked to fewer life-threatening arrhythmias.
Why the study?
Life-threatening ventricular arrhythmia is infrequent in patients with ATTR-CM despite severe cardiac dysfunction, prompting evaluation of LV mechanical dispersion as a marker of arrhythmia substrate compared to other phenotypes with increased LV wall thickness.
Does left ventricular mechanical dispersion (LVMD) distinguish transthyretin amyloidosis cardiomyopathy (ATTR-CM) from non-amyloid LVH and mediate the risk of life-threatening ventricular arrhythmias?
Cohort (n=373)
Does left ventricular mechanical dispersion (LVMD) distinguish transthyretin amyloidosis cardiomyopathy (ATTR-CM) from non-amyloid LVH and mediate the risk of life-threatening ventricular arrhythmias?
Lower left ventricular mechanical dispersion is a distinguishing echocardiographic feature of ATTR-CM that aids in differential diagnosis against other LVH phenotypes and explains the lower rate of life-threatening ventricular arrhythmias.
Answers are grounded in this paper and cite their sources.
Mechanical dispersion may refine arrhythmic risk assessment in LVH phenotypes; hypothesis-generating for ATTR-CM and requires prospective validation.
INTRODUCTION: Life-threatening ventricular arrhythmia (LTVA) is infrequent in patients with transthyretin cardiomyopathy (ATTR-CM) despite severe cardiac dysfunction. We aimed to assess left ventricular mechanical dispersion (LVMD), as a marker of arrhythmia substrate, in ATTR-CM in comparison to other phenotypes with increased left ventricular (LV) wall thickness and in relation to LTVA occurrence. METHODS: Patients with suspected cardiac amyloidosis (CA) and increased LV wall thickness (septal thickness ≥12 mm) were identified. Patients with other types of CA and obstructive hypertrophic cardiomyopathy were excluded. Data from comprehensive clinical assessments, laboratory tests, echocardiography with speckle tracking, and Tc-99m labeled pyrophosphate scintigraphy (PYP) were retrospectively collected from each patient. Diagnosis of ATTR-CM was established based on current recommendations. Longitudinal follow-up was performed over 5 years for LTVA (ventricular tachycardia and sudden cardiac arrest). RESULTS: In ATTR-CM group (n=150) lower LV ejection fraction, impaired global longitudinal strain (GLS), higher LV mass index, smaller end-diastolic volume index and higher relative apical sparing (RAS) were observed compared to the non-amyloid LVH group (n=223). Significantly lower mechanical dispersion (LVMD) was a remarkable feature of ATTR-CM, additive to ESC echocardiography parameters for the differential diagnosis (net reclassification improvement: 0.74). Higher LVMD was associated with increased risk of LTVA, whereas ATTR-CM was associated with a lower risk of LTVA. Mediation analysis further supported the mediating role of LVMD in the association between ATTR-CM and LTVA. CONCLUSION: Lower LVMD seems to be a distinguishing feature of ATTR-CM in association with infrequent LTVA despite severe increased LV wall thickness.
No takes yet. Share an insight, caveat, or question.
Özbay et al. (2026) conducted a cohort in Transthyretin amyloidosis cardiomyopathy (ATTR-CM) and increased left ventricular wall thickness (n=373). Transthyretin cardiomyopathy (ATTR-CM) / Left ventricular mechanical dispersion (LVMD) assessment vs. Non-amyloid left ventricular hypertrophy (LVH) (n=223) was evaluated on Life-threatening ventricular arrhythmia (LTVA: ventricular tachycardia and sudden cardiac arrest) and differential diagnosis of ATTR-CM. ATTR-CM exhibited significantly lower left ventricular mechanical dispersion than non-amyloid LVH (net reclassification improvement 0.74), which mediated a lower risk of life-threatening arrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: